Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrolyzed Collagen Peptide for Collateral Ligament Pain
NCT05971004Completed
- Sponsor
- Tiss'You
- Start
- Apr 2022
- Primary completion
- Oct 2022
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of hydrolysed collagen in Collateral Ligament Injury (2 arms), sponsored by Tiss'You. Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index at 6 months. Started Apr 2022; status: completed.
02
Drugs
hydrolysed collagen
03
Conditions
Collateral Ligament Injury
Beyond the preview
Go deeper on NCT05971004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05971004.